392 related articles for article (PubMed ID: 27751760)
1. Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma.
Zolkind P; Dunn GP; Lin T; Griffith M; Griffith OL; Uppaluri R
Oral Oncol; 2017 Aug; 71():169-176. PubMed ID: 27751760
[TBL] [Abstract][Full Text] [Related]
2. Personalized cancer vaccination in head and neck cancer.
Shibata H; Zhou L; Xu N; Egloff AM; Uppaluri R
Cancer Sci; 2021 Mar; 112(3):978-988. PubMed ID: 33368875
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
Bron L; Romero P
Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
[TBL] [Abstract][Full Text] [Related]
4. The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.
Freiser ME; Serafini P; Weed DT
Immunol Res; 2013 Dec; 57(1-3):52-69. PubMed ID: 24218361
[TBL] [Abstract][Full Text] [Related]
5. Tumor neoantigens: from basic research to clinical applications.
Jiang T; Shi T; Zhang H; Hu J; Song Y; Wei J; Ren S; Zhou C
J Hematol Oncol; 2019 Sep; 12(1):93. PubMed ID: 31492199
[TBL] [Abstract][Full Text] [Related]
6. pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
Zhou C; Wei Z; Zhang Z; Zhang B; Zhu C; Chen K; Chuai G; Qu S; Xie L; Gao Y; Liu Q
Genome Med; 2019 Oct; 11(1):67. PubMed ID: 31666118
[TBL] [Abstract][Full Text] [Related]
7. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
[TBL] [Abstract][Full Text] [Related]
8. Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs.
Cavalieri S; Rivoltini L; Bergamini C; Locati LD; Licitra L; Bossi P
Cancer Treat Rev; 2018 Apr; 65():78-86. PubMed ID: 29574334
[TBL] [Abstract][Full Text] [Related]
9. [Future Prospects on neoplasm antigen vaccine therapy for patients with head and neck squamous cell carcinoma].
Eura M
Nihon Jibiinkoka Gakkai Kaiho; 2002 Mar; 105(3):201-7. PubMed ID: 12014346
[No Abstract] [Full Text] [Related]
10. Advances in personalized neoantigen vaccines for cancer immunotherapy.
Sun C; Xu S
Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
[TBL] [Abstract][Full Text] [Related]
11. Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma.
Voskens CJ; Sewell D; Hertzano R; DeSanto J; Rollins S; Lee M; Taylor R; Wolf J; Suntharalingam M; Gastman B; Papadimitriou JC; Lu C; Tan M; Morales R; Cullen K; Celis E; Mann D; Strome SE
Head Neck; 2012 Dec; 34(12):1734-46. PubMed ID: 22287423
[TBL] [Abstract][Full Text] [Related]
12. [Cancer Vaccine Focused on Neoantigens].
Shindo Y; Hazama S; Nagano H
Gan To Kagaku Ryoho; 2019 Sep; 46(9):1367-1371. PubMed ID: 31530772
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.
Moskovitz JM; Moy J; Seiwert TY; Ferris RL
Oncologist; 2017 Jun; 22(6):680-693. PubMed ID: 28507203
[TBL] [Abstract][Full Text] [Related]
14. Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy.
Richard G; Princiotta MF; Bridon D; Martin WD; Steinberg GD; De Groot AS
Expert Rev Vaccines; 2022 Feb; 21(2):173-184. PubMed ID: 34882038
[TBL] [Abstract][Full Text] [Related]
15. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
Aldous AR; Dong JZ
Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
[TBL] [Abstract][Full Text] [Related]
16. Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma.
Almokadem S
Curr Mol Pharmacol; 2016; 9(3):226-230. PubMed ID: 26177644
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of head and neck cancer.
Resser JR; Carbone DP
Curr Opin Oncol; 1998 May; 10(3):226-32. PubMed ID: 9619359
[TBL] [Abstract][Full Text] [Related]
18. Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck.
Xu Q; Fang M; Zhu J; Dong H; Cao J; Yan L; Leonard F; Oppel F; Sudhoff H; Kaufmann AM; Albers AE; Qian X
Int J Biol Sci; 2020; 16(14):2506-2517. PubMed ID: 32792853
[TBL] [Abstract][Full Text] [Related]
19. The promise of immunotherapy in head and neck squamous cell carcinoma.
Economopoulou P; Agelaki S; Perisanidis C; Giotakis EI; Psyrri A
Ann Oncol; 2016 Sep; 27(9):1675-85. PubMed ID: 27380958
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic neoantigens derived from gene fusions stimulate T cell responses.
Yang W; Lee KW; Srivastava RM; Kuo F; Krishna C; Chowell D; Makarov V; Hoen D; Dalin MG; Wexler L; Ghossein R; Katabi N; Nadeem Z; Cohen MA; Tian SK; Robine N; Arora K; Geiger H; Agius P; Bouvier N; Huberman K; Vanness K; Havel JJ; Sims JS; Samstein RM; Mandal R; Tepe J; Ganly I; Ho AL; Riaz N; Wong RJ; Shukla N; Chan TA; Morris LGT
Nat Med; 2019 May; 25(5):767-775. PubMed ID: 31011208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
